Analysis	O
of	O
the	O
role	O
of	O
protein	B-protein
kinase	I-protein
C-alpha	I-protein
,	I-protein
-epsilon	I-protein
,	I-protein
and	I-protein
-zeta	I-protein
in	O
T	O
cell	O
activation	O
.	O

T	B-cell_type
cells	I-cell_type
express	O
multiple	O
isotypes	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
and	O
although	O
it	O
is	O
well	O
accepted	O
that	O
PKCs	B-protein
have	O
an	O
important	O
role	O
in	O
T	O
cell	O
activation	O
,	O
little	O
is	O
known	O
about	O
the	O
function	O
of	O
individual	O
PKC	B-protein
isotypes	I-protein
.	O

To	O
address	O
this	O
issue	O
,	O
mutationally	O
active	O
PKC-alpha	B-protein
,	I-protein
-epsilon	I-protein
,	I-protein
or	I-protein
-zeta	I-protein
have	O
been	O
transfected	O
into	O
T	B-cell_type
cells	I-cell_type
and	O
the	O
consequences	O
for	O
T	O
cell	O
activation	O
determined	O
.	O

p21ras	B-protein
plays	O
an	O
essential	O
role	O
in	O
T	O
cell	O
activation	O
.	O

Accordingly	O
,	O
the	O
effects	O
of	O
the	O
constitutively	B-protein
active	I-protein
PKCs	I-protein
were	O
compared	O
to	O
the	O
effects	O
of	O
mutationally	O
activated	O
p21ras	B-protein
.	O

The	O
data	O
indicate	O
that	O
PKC-epsilon	B-protein
and	O
,	O
to	O
a	O
lesser	O
extent	O
PKC-alpha	B-protein
but	O
not	O
-zeta	B-protein
,	O
can	O
regulate	O
the	O
transcription	B-protein
factors	I-protein
AP-1	B-protein
and	O
nuclear	O
factor	B-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NF-AT-1	B-protein
)	O
.	O

The	O
ability	O
of	O
PKC-epsilon	B-protein
to	O
induce	O
transactivation	O
of	O
NF-AT-1	B-protein
and	O
AP-1	B-protein
was	O
similar	O
to	O
the	O
stimulatory	O
effect	O
of	O
a	O
constitutively	B-protein
activated	I-protein
p21ras	I-protein
.	O

PKC-epsilon	B-protein
,	O
but	O
not	O
PKC-alpha	B-protein
nor	O
activated	O
p21ras	B-protein
,	O
was	O
able	O
to	O
induce	O
NF-KB	B-protein
activity	O
.	O

Phorbol	O
esters	O
induce	O
expression	O
of	O
CD69	B-protein
whereas	O
none	O
of	O
the	O
activated	B-protein
PKC	I-protein
isotypes	I-protein
tested	O
were	O
able	O
to	O
have	O
this	O
effect	O
.	O

Activated	O
Src	B-protein
and	O
p21ras	B-protein
were	O
able	O
to	O
induce	O
CD69	B-protein
expression	O
.	O

These	O
results	O
indicate	O
selective	O
functions	O
for	O
different	O
PKC	B-protein
isotypes	I-protein
in	O
T	B-cell_type
cells	I-cell_type
.	O

Moreover	O
,	O
the	O
data	O
comparing	O
the	O
effects	O
of	O
activated	B-protein
Ras	I-protein
and	O
PKC	B-protein
mutants	I-protein
suggest	O
that	O
PKC-alpha	B-protein
,	O
p21ras	B-protein
,	O
and	O
PKC-epsilon	B-protein
are	O
not	O
positioned	O
linearly	O
on	O
a	O
single	O
signal	O
transduction	O
pathway	O
.	O

Tag	NULL
JournaL	NULL
or	NULL
BrorocIcat	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

17	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
28	NULL
,	NULL
pp	NULL
.	NULL

9833-9839	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
Role	NULL
of	NULL
Protein	NULL
Kinase	NULL
C-	NULL
«	NULL
,	NULL
-e	NULL
,	NULL
and	NULL
-/	NULL
in	NULL
T	NULL
Cell	NULL
Activation*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
7	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
3	NULL
,	NULL
1995	NULL
)	NULL
Elisabeth	NULL
M.	NULL
Genot	NULL
#	NULL
§	NULL
,	NULL
Peter	NULL
J.	NULL
Parker1	NULL
,	NULL
and	NULL
Doreen	NULL
A.	NULL
Cantrell	NULL
#	NULL
]	NULL
From	NULL
the	NULL
{	NULL
Laboratories	NULL
of	NULL
Lymphocyte	NULL
Activation	NULL
and	NULL
Protein	NULL
Phosphorylation	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
P.	NULL
O0	NULL
.	NULL

123	NULL
,	NULL
Lincoln	NULL
's	NULL
Inn	NULL
Fields	NULL
,	NULL
London	NULL
WC2A	NULL
3PX	NULL
,	NULL
United	NULL
Kingdom	NULL
T	NULL
cells	NULL
express	NULL
multiple	NULL
isotypes	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
and	NULL
although	NULL
it	NULL
is	NULL
well	NULL
accepted	NULL
that	NULL
PKCs	NULL
have	NULL
an	NULL
important	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
function	NULL
of	NULL
individual	NULL
PKC	NULL
isotypes	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
mutationally	NULL
active	NULL
PKC-a	NULL
«	NULL
,	NULL
-e	NULL
,	NULL
or	NULL
-	NULL
{	NULL
have	NULL
been	NULL
transfected	NULL
into	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
consequences	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
determined	NULL
.	NULL

p21	NULL
``	NULL
``	NULL
``	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
constitutively	NULL
active	NULL
PKCs	NULL
were	NULL
compared	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
mutationally	NULL
activated	NULL
p21	NULL
``	NULL
.	NULL

The	NULL
data	NULL
indicate	NULL
that	NULL
PKC-e	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
PKC-a	NULL
«	NULL
but	NULL
not	NULL
-	NULL
{	NULL
,	NULL
can	NULL
regulate	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT-1	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
PKC-e	NULL
to	NULL
induce	NULL
transactivation	NULL
of	NULL
NF-AT-1	NULL
and	NULL
AP-1	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
a	NULL
constitutively	NULL
activated	NULL
p21	NULL
``	NULL
``	NULL
**	NULL
.	NULL

PKC-e	NULL
,	NULL
but	NULL
not	NULL
PKC-a	NULL
«	NULL
nor	NULL
activated	NULL
p21	NULL
*	NULL
``	NULL
,	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
NF-KB	NULL
activity	NULL
.	NULL

Phorbol	NULL
esters	NULL
induce	NULL
expression	NULL
of	NULL
CD69	NULL
whereas	NULL
none	NULL
of	NULL
the	NULL
activated	NULL
PKC	NULL
isotypes	NULL
tested	NULL
were	NULL
able	NULL
to	NULL
have	NULL
this	NULL
effect	NULL
.	NULL

Activated	NULL
Sre	NULL
and	NULL
p21	NULL
``	NULL
``	NULL
were	NULL
able	NULL
to	NULL
induce	NULL
CD69	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
selective	NULL
functions	NULL
for	NULL
different	NULL
PKC	NULL
isotypes	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
data	NULL
comparing	NULL
the	NULL
effects	NULL
of	NULL
activated	NULL
Ras	NULL
and	NULL
PKC	NULL
mutants	NULL
suggest	NULL
that	NULL
PKC-	NULL
«	NULL
,	NULL
p21	NULL
``	NULL
,	NULL
and	NULL
PKC-e	NULL
are	NULL
not	NULL
positioned	NULL
linearly	NULL
on	NULL
a	NULL
single	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
hydrolysis	NULL
of	NULL
inositol	NULL
phospholipids	NULL
and	NULL
the	NULL
resultant	NULL
production	NULL
of	NULL
inositol	NULL
polyphosphates	NULL
and	NULL
diacylglycerols	NULL
that	NULL
regulate	NULL
intracellular	NULL
calcium	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
,	NULL
'	NULL
respectively	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
term	NULL
PKC	NULL
refers	NULL
to	NULL
a	NULL
family	NULL
of	NULL
closely	NULL
related	NULL
serine/threonine	NULL
protein	NULL
kinases	NULL
for	NULL
which	NULL
at	NULL
least	NULL
11	NULL
isotypes	NULL
have	NULL
been	NULL
described	NULL
(	NULL
3	NULL
)	NULL
.	NULL

These	NULL
isotypes	NULL
can	NULL
be	NULL
classified	NULL
according	NULL
to	NULL
their	NULL
structure	NULL
and	NULL
cofactor	NULL
requirements	NULL
for	NULL
activation	NULL
.	NULL

They	NULL
are	NULL
all	NULL
activated	NULL
by	NULL
phospholipids	NULL
and	NULL
,	NULL
with	NULL
notable	NULL
exceptions	NULL
,	NULL
diacylglycerol	NULL
(	NULL
DAG	NULL
)	NULL
via	NULL
an	NULL
allosteric	NULL
mech-anism	NULL
.	NULL

However	NULL
,	NULL
they	NULL
differ	NULL
markedly	NULL
in	NULL
their	NULL
sensitivity	NULL
to	NULL
Ca	NULL
``	NULL
*	NULL
.	NULL

PKC-	NULL
,	NULL
-B1	NULL
,	NULL
-B2	NULL
,	NULL
and	NULL
-y	NULL
are	NULL
dependent	NULL
on	NULL
Ca**	NULL
for	NULL
activity	NULL
,	NULL
whereas	NULL
PKC-e	NULL
,	NULL
-8	NULL
,	NULL
-n	NULL
,	NULL
and	NULL
-0	NULL
are	NULL
not	NULL
.	NULL

PKC-£	NULL
typifies	NULL
a	NULL
third	NULL
group	NULL
of	NULL
PKC	NULL
isotypes	NULL
(	NULL
¢	NULL
,	NULL
A	NULL
,	NULL
:	NULL
)	NULL
which	NULL
also	NULL
structurally	NULL
belong	NULL
to	NULL
the	NULL
PKC	NULL
family	NULL
,	NULL
but	NULL
atypically	NULL
are	NULL
not	NULL
activated	NULL
by	NULL
phorbol	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
A	NULL
member	NULL
of	NULL
INSERM	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
sent	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
071-269-3231	NULL
;	NULL
Fax	NULL
:	NULL
071-269-3417	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
DAG	NULL
,	NULL
diacyl-glycerol	NULL
;	NULL
PDBu	NULL
,	NULL
phorbol	NULL
12,13-dibutyrate	NULL
,	NULL
NF-AT-1	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
NF-ATp	NULL
,	NULL
pre-existing	NULL
factor	NULL
of	NULL
the	NULL
NF-AT-1	NULL
complex	NULL
;	NULL
AP-1	NULL
activating	NULL
protein-1	NULL
;	NULL
NF-KB	NULL
,	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
KB	NULL
sites	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
protein	NULL
kinase	NULL
;	NULL
wt	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

esters	NULL
or	NULL
DAGs	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
fourth	NULL
group	NULL
of	NULL
enzymes	NULL
has	NULL
been	NULL
described	NULL
recently	NULL
that	NULL
bind	NULL
DAG/phorbol	NULL
esters	NULL
and	NULL
have	NULL
structural	NULL
homologies	NULL
with	NULL
the	NULL
PKC	NULL
family	NULL
,	NULL
but	NULL
have	NULL
unusual	NULL
catalytic	NULL
domains	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

PKC	NULL
isotypes	NULL
have	NULL
different	NULL
substrate	NULL
specificity	NULL
in	NULL
vitro	NULL
suggesting	NULL
that	NULL
a	NULL
particular	NULL
PKC	NULL
isotype	NULL
may	NULL
have	NULL
a	NULL
precise	NULL
cellular	NULL
function	NULL
that	NULL
reflects	NULL
its	NULL
cellular	NULL
localization	NULL
and	NULL
substrate	NULL
preferences	NULL
in	NULL
vivo	NULL
.	NULL

PKC	NULL
can	NULL
regulate	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
via	NULL
control	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
en-hancer	NULL
,	NULL
the	NULL
PKC	NULL
responsive	NULL
elements	NULL
include	NULL
sites	NULL
for	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NF-AT-1	NULL
(	NULL
2	NULL
,	NULL
7	NULL
)	NULL
.	NULL

The	NULL
PKC	NULL
controlled	NULL
signaling	NULL
pathways	NULL
that	NULL
regulate	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
not	NULL
fully	NULL
characterized	NULL
but	NULL
may	NULL
involve	NULL
the	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
protein	NULL
p21	NULL
**	NULL
,	NULL
and	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
such	NULL
as	NULL
ERK2	NULL
and	NULL
JNK1	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
express	NULL
multiple	NULL
isotypes	NULL
of	NULL
PKC	NULL
including	NULL
PKC-a	NULL
,	NULL
-B1	NULL
(	NULL
not	NULL
-B2	NULL
)	NULL
,	NULL
-8	NULL
,	NULL
-e	NULL
,	NULL
-n	NULL
,	NULL
-0	NULL
,	NULL
and	NULL
-	NULL
{	NULL
(	NULL
8	NULL
,	NULL
10	NULL
)	NULL
and	NULL
understanding	NULL
the	NULL
role	NULL
of	NULL
these	NULL
different	NULL
isotypes	NULL
of	NULL
PKC	NULL
in	NULL
transcription	NULL
factor	NULL
regulation	NULL
is	NULL
a	NULL
major	NULL
challenge	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
one	NULL
complication	NULL
is	NULL
that	NULL
most	NULL
conclusions	NULL
regarding	NULL
the	NULL
role	NULL
of	NULL
PKC	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
are	NULL
based	NULL
on	NULL
experiments	NULL
that	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
phorbol	NULL
esters	NULL
or	NULL
synthetic	NULL
DAGs	NULL
which	NULL
simultaneously	NULL
activate	NULL
multiple	NULL
isotypes	NULL
of	NULL
PKC	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
that	NULL
phorbol	NULL
esters	NULL
may	NULL
activate	NULL
directly	NULL
non-PKC	NULL
signaling	NULL
pathways	NULL
.	NULL

For	NULL
example	NULL
,	NULL
phorbol	NULL
esters	NULL
can	NULL
bind	NULL
to	NULL
molecules	NULL
other	NULL
than	NULL
PKCs	NULL
such	NULL
as	NULL
rn-chimaerin	NULL
(	NULL
11	NULL
)	NULL
.	NULL

One	NULL
approach	NULL
to	NULL
explore	NULL
the	NULL
role	NULL
of	NULL
a	NULL
signaling	NULL
molecule	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
to	NULL
look	NULL
at	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
transfecting	NULL
cells	NULL
with	NULL
mutated	NULL
constitutively	NULL
active	NULL
signal	NULL
transduction	NULL
molecules	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

PKC	NULL
consists	NULL
of	NULL
a	NULL
carboxyl-terminal	NULL
catalytic	NULL
domain	NULL
and	NULL
an	NULL
regulatory	NULL
domain	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
catalytic	NULL
domain	NULL
is	NULL
inhibited	NULL
by	NULL
a	NULL
pseudosubstrate	NULL
motif	NULL
within	NULL
the	NULL
regulatory	NULL
domain	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Mutational	NULL
activation	NULL
of	NULL
PKC	NULL
by	NULL
complete	NULL
truncation	NULL
of	NULL
the	NULL
regulatory	NULL
domain	NULL
generates	NULL
a	NULL
constitutively	NULL
active	NULL
PKC	NULL
that	NULL
can	NULL
contribute	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
14	NULL
)	NULL
but	NULL
has	NULL
lost	NULL
substrate	NULL
specificity	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
more	NULL
refined	NULL
mechanism	NULL
for	NULL
mutationally	NULL
activating	NULL
PKC	NULL
is	NULL
to	NULL
make	NULL
a	NULL
single	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
PKC	NULL
pseudosubstrate	NULL
sequence	NULL
(	NULL
16	NULL
)	NULL
that	NULL
disrupts	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
catalytic	NULL
site	NULL
and	NULL
the	NULL
pseudosubstrate	NULL
sequence	NULL
,	NULL
but	NULL
retains	NULL
the	NULL
regulatory	NULL
domain	NULL
that	NULL
helps	NULL
determine	NULL
substrate	NULL
specificity	NULL
.	NULL

Such	NULL
PKC	NULL
mutants	NULL
can	NULL
be	NULL
used	NULL
to	NULL
examine	NULL
directly	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
an	NULL
individual	NULL
PKC	NULL
isotype	NULL
,	NULL
independent	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
phorbol	NULL
esters	NULL
or	NULL
DAGs	NULL
.	NULL

Accordingly	NULL
,	NULL
to	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
PKC	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
consequences	NULL
of	NULL
expressing	NULL
pseudosubstrate	NULL
mutated	NULL
PKC-a	NULL
«	NULL
,	NULL
PKC-e	NULL
,	NULL
and	NULL
PKC-£	NULL
.	NULL

These	NULL
three	NULL
isotypes	NULL
were	NULL
selected	NULL
because	NULL
they	NULL
are	NULL
representative	NULL
of	NULL
the	NULL
three	NULL
major	NULL
subdivisions	NULL
in	NULL
the	NULL
PKC	NULL
family	NULL
.	NULL

As	NULL
well	NULL
,	NULL
analysis	NULL
of	NULL
PKC	NULL
translocation	NULL
has	NULL
suggested	NULL
that	NULL
both	NULL
PKC-	NULL
«	NULL
and	NULL
PKC-e	NULL
are	NULL
regulated	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
phorbol	NULL
esters	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
many	NULL
diverse	NULL
PKC	NULL
responses	NULL
that	NULL
could	NULL
be	NULL
explored	NULL
9833	NULL
9834	NULL
in	NULL
this	NULL
type	NULL
of	NULL
analysis	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
look	NULL
at	NULL
the	NULL
regulation	NULL
of	NULL
three	NULL
transcription	NULL
factors	NULL
that	NULL
appear	NULL
PKC	NULL
responsive	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
phorbol	NULL
ester	NULL
experiments	NULL
:	NULL
AP-1	NULL
,	NULL
NF-AT-1	NULL
,	NULL
and	NULL
NF-KB	NULL
.	NULL

We	NULL
also	NULL
looked	NULL
at	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
different	NULL
PKC	NULL
isotypes	NULL
on	NULL
expression	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
antigen	NULL
CD69	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
PKC	NULL
mutants	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
v-src	NULL
,	NULL
a	NULL
constitutively	NULL
active	NULL
tyrosine	NULL
kinase	NULL
,	NULL
and	NULL
constitutively	NULL
active	NULL
p21	NULL
``	NULL
,	NULL
v-Ha-ras	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Reagents-Ionomycin	NULL
(	NULL
Ca**	NULL
salt	NULL
)	NULL
and	NULL
phorbol	NULL
12,13-dibutyrate	NULL
were	NULL
from	NULL
Calbiochem	NULL
Corp.	NULL
(	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

UCHT-1	NULL
(	NULL
reactive	NULL
with	NULL
CD3	NULL
)	NULL
was	NULL
used	NULL
at	NULL
10	NULL
ug/ml	NULL
in	NULL
culture	NULL
.	NULL

[	NULL
**C	NULL
]	NULL
Acetyl	NULL
coenzyme	NULL
A	NULL
(	NULL
at	NULL
50-60	NULL
mCi/mmol	NULL
)	NULL
was	NULL
from	NULL
Amersham	NULL
International	NULL
(	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Other	NULL
reagents	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

Specific	NULL
antisera	NULL
against	NULL
the	NULL
different	NULL
PKC	NULL
isotypes	NULL
were	NULL
raised	NULL
against	NULL
the	NULL
COOH-terminal	NULL
peptide	NULL
from	NULL
the	NULL
proteins	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
against	NULL
rat	NULL
CD2	NULL
(	NULL
OX-34	NULL
)	NULL
or	NULL
p85	NULL
were	NULL
purified	NULL
from	NULL
hybridoma	NULL
supernatants	NULL
.	NULL

Rabbit	NULL
anti-mouse	NULL
and	NULL
goat	NULL
anti-rabbit	NULL
antibodies	NULL
were	NULL
from	NULL
Amersham	NULL
International	NULL
.	NULL

Fluorescein	NULL
isothiocyanate-labeled	NULL
monoclonal	NULL
antibodies	NULL
anti-CD69	NULL
(	NULL
Leu'-FITC	NULL
,	NULL
IgG	NULL
,	NULL
)	NULL
are	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Plasmid	NULL
Constructs-Reporter	NULL
constructs	NULL
;	NULL
NF-KB-CAT	NULL
:	NULL
contains	NULL
3	NULL
copies	NULL
of	NULL
the	NULL
sequence	NULL
for	NULL
the	NULL
NF	NULL
site	NULL
(	NULL
AGCTTGGGACTTTCCATGG-GACTTTCCTAGGGATTCCCC	NULL
)	NULL
,	NULL
and	NULL
AP-1-CAT	NULL
contains	NULL
3	NULL
copies	NULL
of	NULL
the	NULL
sequence	NULL
for	NULL
the	NULL
AP-1	NULL
site	NULL
(	NULL
AGCTATGAGTCTCAGTGATCAGT-GAGTCA	NULL
)	NULL
.	NULL

These	NULL
sequences	NULL
have	NULL
been	NULL
inserted	NULL
in	NULL
pBLCAT2	NULL
to	NULL
generate	NULL
NF-KB-CAT	NULL
and	NULL
AP-1-CAT	NULL
,	NULL
respectively	NULL
(	NULL
18	NULL
)	NULL
.	NULL

NF-AT-CAT	NULL
contains	NULL
3	NULL
copies	NULL
of	NULL
the	NULL
sequence	NULL
5	NULL
'	NULL
corresponding	NULL
to	NULL
the	NULL
sequence	NULL
from	NULL
positions	NULL
-284	NULL
to	NULL
-258	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
minimal	NULL
promoter	NULL
driving	NULL
the	NULL
reporter	NULL
gene	NULL
CAT	NULL
.	NULL

This	NULL
sequence	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
NF-AT-1	NULL
,	NULL
the	NULL
ARRE-2	NULL
site	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
enhancer	NULL
(	NULL
19	NULL
)	NULL
.	NULL

PKC	NULL
Mutants	NULL
and	NULL
Active	NULL
Oncogene	NULL
Containing	NULL
Plasmids-The	NULL
pMT-2	NULL
vector	NULL
was	NULL
used	NULL
to	NULL
express	NULL
PKC-a	NULL
«	NULL
(	NULL
20	NULL
)	NULL
and	NULL
PKC-e	NULL
(	NULL
21	NULL
)	NULL
and	NULL
the	NULL
pCO	NULL
,	NULL
vector	NULL
was	NULL
used	NULL
to	NULL
express	NULL
PKC-£	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
constitutively	NULL
active	NULL
PKC	NULL
clones	NULL
are	NULL
full-length	NULL
a	NULL
,	NULL
e	NULL
,	NULL
and	NULL
{	NULL
cDNAs	NULL
with	NULL
a	NULL
single	NULL
point	NULL
mutation	NULL
in	NULL
their	NULL
inhibitory	NULL
pseudosubstrate	NULL
sequences	NULL
within	NULL
the	NULL
regulatory	NULL
domain	NULL
.	NULL

Mutants	NULL
in	NULL
the	NULL
pseudosubstrate	NULL
sequence	NULL
were	NULL
generated	NULL
by	NULL
substitution	NULL
of	NULL
a	NULL
glutamic	NULL
acid	NULL
for	NULL
an	NULL
alanine	NULL
in	NULL
position	NULL
25	NULL
(	NULL
PKC-	NULL
«	NULL
E25	NULL
)	NULL
,	NULL
position	NULL
159	NULL
for	NULL
PKC-e	NULL
(	NULL
PKC-eE159	NULL
)	NULL
,	NULL
and	NULL
position	NULL
119	NULL
for	NULL
PKC-	NULL
{	NULL
(	NULL
PKC-£E119	NULL
)	NULL
.	NULL

The	NULL
PKC-a	NULL
«	NULL
and	NULL
PKC-	NULL
mutants	NULL
are	NULL
known	NULL
to	NULL
be	NULL
constitutively	NULL
active	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
16	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
wild	NULL
type	NULL
(	NULL
wt	NULL
)	NULL
counterparts	NULL
of	NULL
these	NULL
mutants	NULL
PKC-a	NULL
wt	NULL
,	NULL
PKC-e	NULL
wt	NULL
,	NULL
and	NULL
PKC-£	NULL
wt	NULL
,	NULL
were	NULL
included	NULL
in	NULL
the	NULL
experiments	NULL
as	NULL
controls	NULL
.	NULL

Other	NULL
plasmids	NULL
directing	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
``	NULL
*	NULL
``	NULL
(	NULL
pEF	NULL
Ras	NULL
)	NULL
,	NULL
v-raf	NULL
(	NULL
pEF	NULL
Raf	NULL
)	NULL
,	NULL
and	NULL
v-src	NULL
(	NULL
pEF	NULL
Sre	NULL
)	NULL
were	NULL
used	NULL
and	NULL
are	NULL
described	NULL
elsewhere	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
CMVrCD2	NULL
construct	NULL
contains	NULL
a	NULL
cytoplasmic	NULL
domain	NULL
truncated	NULL
version	NULL
of	NULL
the	NULL
rat	NULL
CD2	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
purified	NULL
by	NULL
equilibrium	NULL
centrifugation	NULL
in	NULL
CsCVethidium	NULL
bromide	NULL
gradients	NULL
using	NULL
standard	NULL
procedures	NULL
.	NULL

Celis	NULL
and	NULL
Transfections-JH6.2	NULL
,	NULL
a	NULL
subline	NULL
of	NULL
the	NULL
human	NULL
T	NULL
acute	NULL
lymphocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
Jurkat	NULL
(	NULL
26	NULL
)	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat	NULL
inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
humidified	NULL
air	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
via	NULL
electroporation	NULL
(	NULL
gene	NULL
pulser	NULL
:	NULL
Bio-Rad	NULL
,	NULL
UK	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instruc-tions	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
pulsed	NULL
(	NULL
10	NULL
``	NULL
cells/0.5	NULL
ml	NULL
)	NULL
in	NULL
complete	NULL
medium	NULL
at	NULL
960	NULL
microfarads	NULL
and	NULL
340	NULL
mV	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
similar	NULL
plasmid	NULL
mixtures	NULL
were	NULL
pooled	NULL
and	NULL
re-aliquoted	NULL
before	NULL
stimulation	NULL
.	NULL

Transfected	NULL
cultures	NULL
were	NULL
cultured	NULL
and	NULL
stimulated	NULL
as	NULL
indicated	NULL
.	NULL

Conditions	NULL
and	NULL
quantities	NULL
of	NULL
DNA	NULL
for	NULL
transfection	NULL
were	NULL
optimized	NULL
for	NULL
each	NULL
plasmid	NULL
and	NULL
each	NULL
plasmid	NULL
preparation	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
ranged	NULL
from	NULL
20	NULL
to	NULL
35	NULL
%	NULL
.	NULL

For	NULL
the	NULL
reporter	NULL
constructs	NULL
AP-1	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
NF-AT-1	NULL
,	NULL
between	NULL
0.5	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
DNA/1O0	NULL
``	NULL
cells	NULL
was	NULL
used	NULL
.	NULL

For	NULL
v-sre	NULL
and	NULL
v-Ha-ras	NULL
and	NULL
PKC	NULL
expression	NULL
constructs	NULL
,	NULL
5-25	NULL
ug	NULL
of	NULL
DNA/10*	NULL
cells	NULL
was	NULL
used	NULL
.	NULL

Western	NULL
Blots	NULL
Analysis-Total	NULL
cell	NULL
lysates	NULL
were	NULL
resolved	NULL
on	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
poly-vinylidine	NULL
difluoride	NULL
membranes	NULL
(	NULL
Immobilon	NULL
,	NULL
Millipore	NULL
)	NULL
by	NULL
overnight	NULL
Western	NULL
blot	NULL
.	NULL

Membranes	NULL
were	NULL
immersed	NULL
in	NULL
PBS/ITween	NULL
20	NULL
,	NULL
0.5	NULL
%	NULL
,	NULL
(	NULL
PBST	NULL
)	NULL
plus	NULL
5	NULL
%	NULL
milk	NULL
for	NULL
2	NULL
h	NULL
to	NULL
block	NULL
nonspecific	NULL
binding	NULL
.	NULL

Anti-PKC	NULL
isotype	NULL
antisera	NULL
or	NULL
p85	NULL
«	NULL
antibodies	NULL
were	NULL
diluted	NULL
1/3,000	NULL
to	NULL
1/5,000	NULL
in	NULL
PBST	NULL
+	NULL
1	NULL
%	NULL
milk	NULL
and	NULL
were	NULL
allowed	NULL
to	NULL
react	NULL
with	NULL
the	NULL
membrane	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

After	NULL
extensive	NULL
washes	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
1/15,000	NULL
dilution	NULL
of	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
antibodies	NULL
(	NULL
for	NULL
PKC	NULL
immun-sera	NULL
)	NULL
or	NULL
rabbit	NULL
anti-mouse	NULL
Ig	NULL
(	NULL
for	NULL
p85	NULL
antibodies	NULL
)	NULL
in	NULL
PBST	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
the	NULL
washes	NULL
in	NULL
PBST	NULL
and	NULL
PBS	NULL
,	NULL
membrane	NULL
bound	NULL
antibodies	NULL
were	NULL
visualized	NULL
by	NULL
use	NULL
of	NULL
ECL	NULL
Western	NULL
blotting	NULL
de-	NULL
Protein	NULL
Kinase	NULL
C	NULL
in	NULL
T	NULL
Cell	NULL
Activation	NULL
tection	NULL
reagents	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
Kodak	NULL
XS1	NULL
films	NULL
.	NULL

CAT	NULL
Assays-CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cellular	NULL
debris	NULL
as	NULL
pelleted	NULL
and	NULL
the	NULL
lysates	NULL
heated	NULL
at	NULL
68	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
before	NULL
use	NULL
.	NULL

Assay	NULL
conditions	NULL
were	NULL
150	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
0.05	NULL
Ci	NULL
of	NULL
[	NULL
**Clacetyl	NULL
coenzyme	NULL
A	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
chloramphenicol	NULL
.	NULL

Chloramphenicol	NULL
was	NULL
extracted	NULL
with	NULL
ethyl	NULL
acetate	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
the	NULL
acetylated	NULL
products	NULL
and	NULL
nonacetylated	NULL
substrate	NULL
of	NULL
each	NULL
reaction	NULL
was	NULL
determined	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
of	NULL
organic	NULL
and	NULL
aqueous	NULL
phases	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
chloramphenicol	NULL
acetylation	NULL
is	NULL
calculated	NULL
and	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
such	NULL
or	NULL
as	NULL
-fold	NULL
increase	NULL
of	NULL
the	NULL
control	NULL
response	NULL
.	NULL

FACS	NULL
Analysis-Cells	NULL
were	NULL
incubated	NULL
with	NULL
FITC-conjugated	NULL
Leu**	NULL
antibodies	NULL
(	NULL
human	NULL
CD69	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PBS	NULL
containing	NULL
4	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
prior	NULL
to	NULL
analysis	NULL
with	NULL
a	NULL
FACScan	NULL
fluorocytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
rat	NULL
CD2	NULL
and	NULL
human	NULL
CD3	NULL
antigens	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
ug/ml	NULL
OX-34	NULL
(	NULL
rat	NULL
CD2	NULL
)	NULL
or	NULL
UCHT-1	NULL
(	NULL
human	NULL
CD3	NULL
)	NULL
antibodies	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
thereafter	NULL
incubated	NULL
with	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
rabbit	NULL
anti-mouse	NULL
immunoglobulin	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
prior	NULL
to	NULL
FACS	NULL
analysis	NULL
.	NULL

Propidium	NULL
iodide	NULL
was	NULL
used	NULL
to	NULL
exclude	NULL
dead	NULL
cells	NULL
from	NULL
analysis	NULL
.	NULL

RESULTS	NULL
PKC-a	NULL
and	NULL
PKC-e	NULL
Are	NULL
Able	NULL
to	NULL
Induce	NULL
AP-1	NULL
Activity	NULL
in	NULL
Jurkat	NULL
Cells-In	NULL
fibroblasts	NULL
,	NULL
expression	NULL
of	NULL
pseudosubstrate	NULL
mutated	NULL
PKC-a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
AP-1	NULL
activity	NULL
(	NULL
16	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
mutated	NULL
constitutively	NULL
active	NULL
PKC-	NULL
,	NULL
-e	NULL
,	NULL
and	NULL
-	NULL
{	NULL
to	NULL
induce	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
employed	NULL
transient	NULL
transfection	NULL
protocols	NULL
and	NULL
quantitation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
whose	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
AP-1-CAT	NULL
construct	NULL
plus	NULL
one	NULL
of	NULL
the	NULL
expression	NULL
constructs	NULL
encoding	NULL
the	NULL
different	NULL
PKC	NULL
isotypes	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
harvested	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
AP-1-CAT	NULL
activity	NULL
was	NULL
determined	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Basal	NULL
AP-1	NULL
activity	NULL
measured	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulus	NULL
,	NULL
is	NULL
low	NULL
and	NULL
PDBu	NULL
induced	NULL
a	NULL
6-8-fold	NULL
increase	NULL
in	NULL
the	NULL
AP-1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
and	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
cotransfection	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
,	NULL
p21	NULL
%	NULL
``	NULL
*	NULL
``	NULL
*	NULL
,	NULL
induced	NULL
a	NULL
level	NULL
of	NULL
AP-1	NULL
activity	NULL
comparable	NULL
to	NULL
the	NULL
level	NULL
of	NULL
PDBu	NULL
induced	NULL
AP-1	NULL
activity	NULL
.	NULL

Similarily	NULL
cotransfection	NULL
of	NULL
v-sre	NULL
,	NULL
a	NULL
constitutively	NULL
active	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
resulted	NULL
in	NULL
transactivation	NULL
of	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

When	NULL
PKC	NULL
mutants	NULL
were	NULL
cotransfected	NULL
with	NULL
AP-1	NULL
in	NULL
an	NULL
identical	NULL
procedure	NULL
,	NULL
PKC-eE159	NULL
and	NULL
PKC-aB25	NULL
were	NULL
found	NULL
to	NULL
transactivate	NULL
the	NULL
AP-1-CAT	NULL
reporter	NULL
construct	NULL
.	NULL

PKC-eE159	NULL
induced	NULL
a	NULL
level	NULL
of	NULL
AP-1-CAT	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
phorbol	NULL
ester-stimulated	NULL
cells	NULL
,	NULL
whereas	NULL
PKC-aB25	NULL
was	NULL
consistently	NULL
less	NULL
effective	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
compare	NULL
the	NULL
kinetics	NULL
of	NULL
AP-1	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
PKC-aBE25	NULL
and	NULL
PKC-eE159	NULL
mutants	NULL
and	NULL
show	NULL
that	NULL
the	NULL
kinetics	NULL
of	NULL
AP-1	NULL
induction	NULL
by	NULL
the	NULL
two	NULL
isotypes	NULL
are	NULL
similar	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

AP-1-CAT	NULL
activity	NULL
was	NULL
not	NULL
regulated	NULL
by	NULL
the	NULL
mutant	NULL
nor	NULL
by	NULL
cotransfection	NULL
of	NULL
expression	NULL
plasmid	NULL
encoding	NULL
wild	NULL
type	NULL
PKC-a	NULL
@	NULL
,	NULL
-e	NULL
,	NULL
or	NULL
-	NULL
{	NULL
.	NULL

Increasing	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
PKC-£E119	NULL
expression	NULL
vector	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
AP-1	NULL
activity	NULL
at	NULL
any	NULL
time	NULL
point	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
failure	NULL
of	NULL
the	NULL
PKC-¢E119	NULL
mutant	NULL
to	NULL
transactivate	NULL
AP-1	NULL
was	NULL
due	NULL
to	NULL
insufficient	NULL
expression	NULL
of	NULL
the	NULL
enzyme	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
PKC	NULL
isotypes	NULL
in	NULL
transfected	NULL
cells	NULL
was	NULL
performed	NULL
.	NULL

JH6.2	NULL
cells	NULL
constitutively	NULL
express	NULL
PKC-	NULL
«	NULL
,	NULL
-e	NULL
,	NULL
and	NULL
-£	NULL
.	NULL

The	NULL
point	NULL
mutated	NULL
PKC	NULL
isotypes	NULL
will	NULL
migrate	NULL
at	NULL
a	NULL
similar	NULL
molecular	NULL
weight	NULL
as	NULL
the	NULL
endogenous	NULL
isotypes	NULL
and	NULL
have	NULL
an	NULL
identical	NULL
immunoreactivity	NULL
as	NULL
the	NULL
endogenous	NULL
enzyme	NULL
.	NULL

However	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
total	NULL
cellular	NULL
levels	NULL
of	NULL
the	NULL
particular	NULL
PKC	NULL
isotype	NULL
is	NULL
an	NULL
indication	NULL
that	NULL
the	NULL
transfected	NULL
gene	NULL
is	NULL
efficiently	NULL
transcribed	NULL
and	NULL
translated	NULL
into	NULL
the	NULL
final	NULL
PKC	NULL
product	NULL
.	NULL

The	NULL
Western	NULL
blots	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
show	NULL
that	NULL
endogenous	NULL
detected	NULL
in	NULL
control	NULL
empty	NULL
vector	NULL
transfected	NULL
cells	NULL
,	NULL
migrates	NULL
as	NULL
an	NULL
80-kDa	NULL
band	NULL
.	NULL

PKC-	NULL
{	NULL
E119	NULL
levels	NULL
increased	NULL
with	NULL
the	NULL
time	NULL
after	NULL
transfection	NULL
to	NULL
reach	NULL
a	NULL
maxi-	NULL
Protein	NULL
Kinase	NULL
C	NULL
in	NULL
T	NULL
Cell	NULL
Activation	NULL
A	NULL
AP-1-CAT	NULL
fold	NULL
induction	NULL
of	NULL
the	NULL
control	NULL
response	NULL
empty	NULL
empty+PdBu	NULL
v-src	NULL
v-Ha-ras	NULL
2	NULL
51	NULL
B	NULL
7	NULL
AP-1-CAT	NULL
°_	NULL
.a	NULL
Hee	NULL
4	NULL
mapa	NULL
?	NULL

empty	NULL
empty	NULL
E25	NULL
wt	NULL
E159	NULL
wt	NULL
E119	NULL
wt	NULL
PKC	NULL
G	NULL
_	NULL
PKCE	NULL
_	NULL
PKC-	NULL
C	NULL
o	NULL
|C	NULL
|	NULL
--	NULL
-m	NULL
--	NULL
empty	NULL
vector	NULL
AP-1-CAT	NULL
empty	NULL
vector	NULL
+	NULL
PdBu	NULL
100	NULL
4	NULL
--	NULL
-	NULL
_	NULL
PKC-alpha	NULL
E25	NULL
--	NULL
#	NULL
&	NULL
~~	NULL
-	NULL
PKC-epsilon	NULL
E159	NULL
co	NULL
O	NULL
i	NULL
%	NULL
conversion	NULL
O	NULL
O	NULL
1	NULL
$	NULL
O	NULL
i	NULL
time	NULL
post	NULL
transfection	NULL
(	NULL
h	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PKC-eE159	NULL
,	NULL
PKC-	NULL
«	NULL
E25	NULL
,	NULL
and	NULL
PKC-	NULL
{	NULL
119	NULL
on	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
with	NULL
the	NULL
AP-1-CAT	NULL
reporter	NULL
construct	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
a	NULL
v-src	NULL
or	NULL
v-Ha-ras	NULL
containing	NULL
plasmids	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
immediately	NULL
after	NULL
transfection	NULL
for	NULL
18	NULL
h	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
,	NULL
and	NULL
CAT	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Data	NULL
show	NULL
fold	NULL
increase	NULL
of	NULL
the	NULL
control	NULL
response	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
activity	NULL
calculated	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
conversion	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
PDBu-stimulated	NULL
cells	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
v-sre	NULL
or	NULL
v-Ha-ras	NULL
versus	NULL
control	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
four	NULL
are	NULL
presented	NULL
.	NULL

B	NULL
,	NULL
the	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
A	NULL
except	NULL
that	NULL
one	NULL
of	NULL
a	NULL
PKC-a	NULL
,	NULL
-e	NULL
,	NULL
-	NULL
{	NULL
mutant	NULL
or	NULL
wild	NULL
type	NULL
PKCs	NULL
was	NULL
cotransfected	NULL
together	NULL
with	NULL
AP-1-CAT	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
seven	NULL
experiments	NULL
.	NULL

For	NULL
these	NULL
seven	NULL
experiments	NULL
the	NULL
mean	NULL
fold	NULL
increase	NULL
9835	NULL
r	NULL
--	NULL
PKC	NULL
-	NULL
{	NULL
E	NULL
119	NULL
M.W	NULL
.	NULL

3	NULL
(	NULL
kDa	NULL
_	NULL
&	NULL
$	NULL
oS	NULL
¢	NULL
6	NULL
9	NULL
&	NULL
a	NULL
97	NULL
-	NULL
f	NULL
vic-	NULL
;	NULL
-+|	NULL
b	NULL
p85	NULL
-	NULL
0	NULL
.	NULL

-	NULL
»	NULL
]	NULL
sou	NULL
»	NULL
axe	NULL
amas	NULL
«	NULL
om	NULL
»	NULL
4	NULL
goa	NULL
amas	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

PKC-£E119	NULL
is	NULL
expressed	NULL
in	NULL
pCO	NULL
,	NULL
-PKC-£E119	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
PKC-£E119	NULL
or	NULL
the	NULL
empty	NULL
vector	NULL
and	NULL
total	NULL
cellular	NULL
extracts	NULL
prepared	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
after	NULL
transfection	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
p85	NULL
«	NULL
subunit	NULL
of	NULL
phos-phatidylinositol	NULL
3-kinase	NULL
kinase	NULL
,	NULL
monitored	NULL
to	NULL
control	NULL
the	NULL
loading	NULL
of	NULL
the	NULL
gel	NULL
,	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
bottom	NULL
panel	NULL
.	NULL

mum	NULL
level	NULL
16	NULL
h	NULL
post-transfection	NULL
.	NULL

This	NULL
level	NULL
was	NULL
maintained	NULL
for	NULL
at	NULL
least	NULL
24	NULL
h.	NULL
The	NULL
failure	NULL
of	NULL
the	NULL
PKC-	NULL
{	NULL
E119	NULL
mutant	NULL
to	NULL
transactivate	NULL
AP-1	NULL
was	NULL
thus	NULL
not	NULL
due	NULL
to	NULL
insufficient	NULL
expression	NULL
of	NULL
the	NULL
enzyme	NULL
.	NULL

Jurkat	NULL
cells	NULL
constitutively	NULL
express	NULL
PKC-a	NULL
and	NULL
-e.	NULL
The	NULL
functional	NULL
effects	NULL
of	NULL
the	NULL
mutated	NULL
PKC-a	NULL
«	NULL
E25	NULL
and	NULL
PKC-eE159	NULL
were	NULL
easy	NULL
to	NULL
demonstrate	NULL
but	NULL
no	NULL
increases	NULL
in	NULL
the	NULL
total	NULL
level	NULL
of	NULL
PKC-a	NULL
«	NULL
and	NULL
-e	NULL
were	NULL
detected	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
PKC-aB25	NULL
and	NULL
PKC-eE159	NULL
mutants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Endogenous	NULL
PKC-a	NULL
and	NULL
-e	NULL
are	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
activated	NULL
mutants	NULL
are	NULL
expressed	NULL
at	NULL
a	NULL
low	NULL
level	NULL
relative	NULL
to	NULL
the	NULL
endogenous	NULL
wild	NULL
type	NULL
enzyme	NULL
.	NULL

PKC-a	NULL
and	NULL
PKC-e	NULL
Are	NULL
Able	NULL
to	NULL
Induce	NULL
NF-AT-1	NULL
Activity-The	NULL
transcriptional	NULL
factor	NULL
NF-AT-1	NULL
is	NULL
a	NULL
complex	NULL
of	NULL
AP-1	NULL
and	NULL
NF-ATp	NULL
(	NULL
7	NULL
)	NULL
.	NULL

There	NULL
is	NULL
a	NULL
two-signal	NULL
requirement	NULL
for	NULL
NF-AT-1	NULL
activation	NULL
which	NULL
reflects	NULL
that	NULL
calcium	NULL
regulated	NULL
signals	NULL
induce	NULL
NF-ATp	NULL
translocation	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
whereas	NULL
PKC	NULL
or	NULL
p21	NULL
``	NULL
is	NULL
proposed	NULL
to	NULL
induce	NULL
AP-1	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
show	NULL
that	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
alone	NULL
has	NULL
a	NULL
weak	NULL
inductive	NULL
effect	NULL
on	NULL
NF-AT-1	NULL
but	NULL
ionomycin	NULL
and	NULL
PDBu	NULL
synergize	NULL
for	NULL
maximal	NULL
activation	NULL
.	NULL

Expression	NULL
of	NULL
v-sre	NULL
can	NULL
substitute	NULL
for	NULL
both	NULL
ionomycin	NULL
and	NULL
PDBu	NULL
signals	NULL
and	NULL
transactivate	NULL
NF-AT-CAT	NULL
.	NULL

The	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
,	NULL
v-Ha-ras	NULL
alone	NULL
,	NULL
has	NULL
no	NULL
inductive	NULL
effect	NULL
on	NULL
NF-AT-1	NULL
,	NULL
but	NULL
can	NULL
synergize	NULL
with	NULL
ionomycin	NULL
for	NULL
NF-AT-1	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
role	NULL
of	NULL
PKC	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
active	NULL
NF-AT-1	NULL
complex	NULL
,	NULL
cotransfection	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
PKC-eE159	NULL
,	NULL
PKC-oE25	NULL
,	NULL
and	NULL
PKC-	NULL
{	NULL
E119	NULL
mutants	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
show	NULL
that	NULL
the	NULL
PKC-eE159	NULL
and	NULL
PKC-aE25	NULL
mutants	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
NF-AT-1	NULL
activity	NULL
but	NULL
were	NULL
able	NULL
to	NULL
induce	NULL
NF-AT-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ionomycin	NULL
.	NULL

Neither	NULL
PKC-£	NULL
{	NULL
E119	NULL
,	NULL
nor	NULL
the	NULL
wild	NULL
type	NULL
PKC-a	NULL
«	NULL
,	NULL
-e	NULL
,	NULL
and	NULL
-	NULL
{	NULL
isotypes	NULL
were	NULL
able	NULL
to	NULL
induce	NULL
significant	NULL
NF-AT-CAT	NULL
activity	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
ionomycin	NULL
.	NULL

PKC	NULL
is	NULL
proposed	NULL
to	NULL
regulate	NULL
NF-AT-1	NULL
via	NULL
effects	NULL
on	NULL
AP-1	NULL
.	NULL

The	NULL
PKC-eE159	NULL
mutant	NULL
was	NULL
repeatedly	NULL
more	NULL
effective	NULL
than	NULL
PKC-	NULL
«	NULL
E25	NULL
for	NULL
NF-AT-1	NULL
induction	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
relative	NULL
potency	NULL
of	NULL
these	NULL
constructs	NULL
on	NULL
AP-1	NULL
activity	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
kinetic	NULL
experiments	NULL
,	NULL
the	NULL
synergy	NULL
between	NULL
ionomycin	NULL
and	NULL
PKC-eE159	NULL
and	NULL
PKC-aE25	NULL
mutants	NULL
for	NULL
NF-AT-CAT	NULL
induction	NULL
were	NULL
readily	NULL
detected	NULL
2	NULL
h	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

of	NULL
the	NULL
control	NULL
response	NULL
for	NULL
PDBu-	NULL
,	NULL
PKC-aE25-	NULL
,	NULL
and	NULL
PKC-eE159-treated	NULL
cells	NULL
was	NULL
10	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
.	NULL

C	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
AP-1-CAT	NULL
reporter	NULL
construct	NULL
and	NULL
empty	NULL
vector	NULL
or	NULL
PKC-aE25	NULL
or	NULL
PKC-eE159	NULL
plasmids	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
immediately	NULL
after	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
transfection	NULL
and	NULL
the	NULL
data	NULL
show	NULL
the	NULL
CAT	NULL
activity	NULL
as	NULL
percentage	NULL
conversion	NULL
monitored	NULL
from	NULL
cell	NULL
extracts	NULL
.	NULL

9836	NULL
PKC-e	NULL
Is	NULL
Able	NULL
to	NULL
Induce	NULL
NF-KB	NULL
Activity-NF-KB	NULL
,	NULL
a	NULL
PKC-regulated	NULL
transcription	NULL
factor	NULL
,	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
2	NULL
DNA	NULL
binding	NULL
subunits	NULL
which	NULL
are	NULL
members	NULL
of	NULL
the	NULL
re	NULL
?	NULL

family	NULL
(	NULL
27	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
different	NULL
PKC	NULL
isotypes	NULL
to	NULL
transactivate	NULL
NF-KB	NULL
,	NULL
PKC-eE159	NULL
,	NULL
PKC-aE25	NULL
,	NULL
and	NULL
PKC-	NULL
{	NULL
E119	NULL
expression	NULL
constructs	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
NF-KB-CAT	NULL
construct	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
harvested	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
cotransfection	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
constitutively	NULL
activated	NULL
Ras	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
and	NULL
an	NULL
activated	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
,	NULL
v-src	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
a	NULL
show	NULL
that	NULL
NF-KB-CAT	NULL
activity	NULL
in	NULL
unstimulated	NULL
JH6.2	NULL
cells	NULL
can	NULL
be	NULL
increased	NULL
3-4-fold	NULL
with	NULL
phorbol	NULL
ester	NULL
stimulation	NULL
.	NULL

Cotransfection	NULL
of	NULL
an	NULL
activated	NULL
tyrosine	NULL
kinase	NULL
v-srce	NULL
was	NULL
also	NULL
able	NULL
to	NULL
increase	NULL
NF-KB	NULL
activity	NULL
2-3-fold	NULL
,	NULL
but	NULL
constitutively	NULL
active	NULL
v-Ha-ras	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
.	NULL

This	NULL
was	NULL
in	NULL
marked	NULL
contrast	NULL
to	NULL
the	NULL
strong	NULL
transactivating	NULL
effect	NULL
of	NULL
the	NULL
Ras	NULL
mutant	NULL
on	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
(	NULL
Figs	NULL
.	NULL

1A	NULL
and	NULL
34	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
only	NULL
PKC-eE159	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
NF-KB	NULL
activity	NULL
,	NULL
and	NULL
cotransfections	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
PKC-a625	NULL
or	NULL
PKC-	NULL
{	NULL
E119	NULL
mutants	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
NF-KB-CAT	NULL
activity	NULL
.	NULL

In	NULL
kinetic	NULL
experiments	NULL
,	NULL
NF-KB	NULL
activity	NULL
was	NULL
detected	NULL
between	NULL
2	NULL
and	NULL
4	NULL
h	NULL
after	NULL
transfection	NULL
of	NULL
PKC-eE159	NULL
,	NULL
whereas	NULL
no	NULL
significant	NULL
effect	NULL
of	NULL
PKC-oB25	NULL
or	NULL
PKC-	NULL
{	NULL
E119	NULL
mutants	NULL
was	NULL
detected	NULL
at	NULL
any	NULL
time	NULL
point	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

PKC-a	NULL
,	NULL
PKC-e	NULL
,	NULL
PKC-	NULL
{	NULL
Are	NULL
Unable	NULL
to	NULL
Induce	NULL
CD69	NULL
Expres-sion-The	NULL
CD69	NULL
antigen	NULL
is	NULL
rapidly	NULL
expressed	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
in	NULL
response	NULL
to	NULL
triggering	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
or	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
phorbol	NULL
esters	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
phorbol	NULL
ester	NULL
led	NULL
to	NULL
the	NULL
conclusion	NULL
that	NULL
PKC	NULL
controls	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
CD69	NULL
.	NULL

It	NULL
is	NULL
now	NULL
also	NULL
recognized	NULL
that	NULL
p21	NULL
``	NULL
``	NULL
is	NULL
involved	NULL
in	NULL
CD69	NULL
induction	NULL
.	NULL

Thus	NULL
transfection	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
into	NULL
Jurkat	NULL
cells	NULL
induces	NULL
CD69	NULL
expression	NULL
,	NULL
whereas	NULL
transfection	NULL
of	NULL
a	NULL
dominant	NULL
negative	NULL
Ras	NULL
mutant	NULL
prevents	NULL
phorbol	NULL
ester	NULL
regulation	NULL
of	NULL
this	NULL
surface	NULL
antigen	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
identify	NULL
which	NULL
isotype	NULL
of	NULL
PKC	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
CD69	NULL
molecule	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
plasmids	NULL
encoding	NULL
the	NULL
different	NULL
PKC	NULL
mutants	NULL
were	NULL
transfected	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
monitored	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

Results	NULL
of	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Optimal	NULL
conditions	NULL
to	NULL
follow	NULL
the	NULL
induction	NULL
of	NULL
CD69	NULL
by	NULL
a	NULL
transfected	NULL
plasmid	NULL
were	NULL
established	NULL
by	NULL
using	NULL
the	NULL
constitutively	NULL
active	NULL
v-sre	NULL
construct	NULL
.	NULL

Fig	NULL
.	NULL

5a	NULL
shows	NULL
that	NULL
the	NULL
JH6.2	NULL
subclone	NULL
of	NULL
Jurkat	NULL
does	NULL
not	NULL
express	NULL
CD69	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulus	NULL
but	NULL
PDBu	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
CD69	NULL
expression	NULL
.	NULL

In	NULL
cells	NULL
transfected	NULL
with	NULL
v-src	NULL
,	NULL
a	NULL
subpopulation	NULL
of	NULL
cells	NULL
can	NULL
be	NULL
seen	NULL
to	NULL
express	NULL
CD69	NULL
to	NULL
levels	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
the	NULL
PDBu-stimulated	NULL
cells	NULL
.	NULL

Phorbol	NULL
esters	NULL
will	NULL
activate	NULL
all	NULL
of	NULL
the	NULL
Jurkat	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
efficiency	NULL
in	NULL
transient	NULL
transfection	NULL
protocols	NULL
means	NULL
that	NULL
only	NULL
a	NULL
subpopulation	NULL
of	NULL
cells	NULL
will	NULL
express	NULL
the	NULL
activated	NULL
Sre	NULL
mutants	NULL
.	NULL

Thus	NULL
in	NULL
each	NULL
experiment	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
expression	NULL
construct	NULL
encoding	NULL
a	NULL
truncated	NULL
rat	NULL
CD2	NULL
antigen	NULL
as	NULL
a	NULL
surface	NULL
tag	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
can	NULL
then	NULL
be	NULL
estimated	NULL
by	NULL
fluorescence	NULL
analysis	NULL
of	NULL
rat	NULL
CD2	NULL
expression	NULL
.	NULL

In	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
transfection	NULL
efficiency	NULL
from	NULL
the	NULL
CD2	NULL
analysis	NULL
was	NULL
35	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
and	NULL
in	NULL
the	NULL
v-src	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5¢c	NULL
)	NULL
,	NULL
a	NULL
comparable	NULL
percentage	NULL
of	NULL
the	NULL
cells	NULL
became	NULL
CD69	NULL
positive	NULL
,	NULL
with	NULL
a	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
PDBu-stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
activated	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
also	NULL
induced	NULL
CD69	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5d	NULL
)	NULL
so	NULL
that	NULL
approximately	NULL
15	NULL
%	NULL
of	NULL
cells	NULL
became	NULL
CD69	NULL
positive	NULL
.	NULL

CD3	NULL
expression	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
transfection	NULL
of	NULL
v-src	NULL
or	NULL
v-Ha-ras	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
weaker	NULL
effect	NULL
of	NULL
v-Ha-ras	NULL
compared	NULL
to	NULL
v-sre	NULL
was	NULL
consistently	NULL
observed	NULL
in	NULL
seven	NULL
experiments	NULL
.	NULL

There	NULL
was	NULL
no	NULL
synergy	NULL
between	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
or	NULL
activated	NULL
Ras	NULL
and	NULL
ionomycin	NULL
for	NULL
CD69	NULL
expression	NULL
.	NULL

CD69	NULL
induction	NULL
was	NULL
never	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
PKC-	NULL
@	NULL
B25	NULL
,	NULL
PKC-eE159	NULL
,	NULL
or	NULL
PKC	NULL
Protein	NULL
Kinase	NULL
C	NULL
in	NULL
T	NULL
Cell	NULL
Activation	NULL
80	NULL
A	NULL
|M	NULL
nil	NULL
NFAT-CAT	NULL
(	NULL
3	NULL
ionomycin	NULL
60	NULL
4	NULL
5	NULL
9	NULL
8	NULL
&	NULL
407	NULL
6	NULL
o	NULL
3	NULL
20	NULL
o-J	NULL
«	NULL
empty	NULL
empty+PdBu	NULL
v-sre	NULL
v-Ha-ras	NULL
50	NULL
B	NULL
M	NULL
nil	NULL
NFAT-CAT	NULL
ionomycin	NULL
ao	NULL
{	NULL
so	NULL
ull	NULL
2	NULL
0	NULL
304	NULL
g	NULL
0	NULL
>	NULL
a	NULL
8	NULL
201	NULL
&	NULL
107	NULL
empty	NULL
empty	NULL
E25	NULL
wt	NULL
E159	NULL
wt	NULL
E119	NULL
_	NULL
wt	NULL
+	NULL
PdBu	NULL
PKC-	NULL
&	NULL
PKC-	NULL
g	NULL
PKC-	NULL
C	NULL
40	NULL
C	NULL
|	NULL
--	NULL
-=-~-	NULL
_	NULL
empty	NULL
vector	NULL
NFAT-CAT	NULL
-A-	NULL
_	NULL
empty	NULL
vector+Pdbu	NULL
304	NULL
-	NULL
{	NULL
T	NULL
``	NULL
0~~	NULL
PKC-alpha	NULL
E25	NULL
a	NULL
m~-	NULL
#	NULL
*~~	NULL
-	NULL
PKC-epsilon	NULL
E159	NULL
|	NULL
e	NULL
9	NULL
207	NULL
a	NULL
6	NULL
O	NULL
s	NULL
10	NULL
_-_	NULL
,	NULL
BRn	NULL
--	NULL
--	NULL
-	NULL
~~	NULL
``	NULL
CC	NULL
_	NULL
--	NULL
``	NULL
o	NULL
Ree	NULL
*-	NULL
,	NULL
r	NULL
+-0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
time	NULL
post	NULL
stimulation	NULL
(	NULL
h	NULL
)	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Constitutively	NULL
active	NULL
PKC-eE159	NULL
and	NULL
PKC-	NULL
«	NULL
E25	NULL
but	NULL
not	NULL
PKC-	NULL
119	NULL
are	NULL
able	NULL
to	NULL
synergize	NULL
with	NULL
ionomycin	NULL
to	NULL
induce	NULL
NF-AT-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NF-AT-CAT	NULL
and	NULL
either	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
v-sre	NULL
or	NULL
v-Ha-ras	NULL
expression	NULL
plasmids	NULL
.	NULL

After	NULL
12	NULL
h	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
then	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
and/or	NULL
0.5	NULL
ug/ml	NULL
ionomycin	NULL
for	NULL
8	NULL
h	NULL
,	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
CAT	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

B	NULL
,	NULL
the	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
A	NULL
except	NULL
that	NULL
one	NULL
of	NULL
the	NULL
PKC-	NULL
@	NULL
,	NULL
-e	NULL
,	NULL
-	NULL
{	NULL
mutant	NULL
or	NULL
wild	NULL
type	NULL
expression	NULL
vector	NULL
were	NULL
cotransfected	NULL
with	NULL
NF-AT-CAT	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
data	NULL
show	NULL
CAT	NULL
activity	NULL
as	NULL
percentage	NULL
conversion	NULL
and	NULL
are	NULL
one	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
seven	NULL
.	NULL

C	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
NF-AT-CAT	NULL
reporter	NULL
construct	NULL
and	NULL
PKC-	NULL
«	NULL
B25	NULL
or	NULL
PKC-	NULL
«	NULL
E159	NULL
or	NULL
PKC-	NULL
{	NULL
E119	NULL
plasmids	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
express	NULL
the	NULL
PKC	NULL
gene	NULL
for	NULL
12	NULL
h	NULL
and	NULL
stimuli	NULL
were	NULL
then	NULL
applied	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
plus	NULL
ionomycin	NULL
,	NULL
while	NULL
ionomycin	NULL
alone	NULL
was	NULL
then	NULL
added	NULL
to	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
PKCs	NULL
mutants	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
extracts	NULL
made	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
are	NULL
presented	NULL
.	NULL

Protein	NULL
Kinase	NULL
C	NULL
in	NULL
T	NULL
Cell	NULL
Activation	NULL
A	NULL
NF-KB-CAT	NULL
fold	NULL
induction	NULL
of	NULL
the	NULL
control	NULL
response	NULL
empty	NULL
-	NULL
empty+PdBu	NULL
_-	NULL
v-sre	NULL
_-	NULL
v-Ha-ras	NULL
é	NULL
5	NULL
.	NULL

B	NULL
y	NULL
NF-KB-CAT	NULL
om	NULL
1001	NULL
O	NULL
ge	NULL
empty	NULL
empt	NULL
wt	NULL
w	NULL
w	NULL
*	NULL
spdBu	NULL
PKC	NULL
.	NULL

@	NULL
-	NULL
PKCE	NULL
-	NULL
PKC-L	NULL
``	NULL
TC	NULL
-==-	NULL
empty	NULL
vector	NULL
NF-KB-CAT	NULL
--	NULL
-	NULL
_-	NULL
empty	NULL
vector	NULL
+	NULL
PdBu	NULL
40	NULL
7	NULL
--	NULL
O-	NULL
_	NULL
PKC-alpha	NULL
E25	NULL
P	NULL
m-	NULL
-	NULL
PKC-epsilon	NULL
E159	NULL
é	NULL
30	NULL
{	NULL
107	NULL
1	NULL
0	NULL
0	NULL
time	NULL
post	NULL
transfection	NULL
(	NULL
h	NULL
)	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PKC-	NULL
«	NULL
,	NULL
-e	NULL
,	NULL
and	NULL
-	NULL
{	NULL
on	NULL
NF-KB	NULL
induction	NULL
.	NULL

A	NULL
,	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NF-KB-CAT	NULL
reporter	NULL
construct	NULL
and	NULL
empty	NULL
vector	NULL
or	NULL
v-sre	NULL
or	NULL
v-Ha-ras	NULL
containing	NULL
plasmids	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
immediately	NULL
after	NULL
transfection	NULL
for	NULL
18	NULL
h	NULL
,	NULL
before	NULL
extracts	NULL
were	NULL
made	NULL
,	NULL
and	NULL
CAT	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

The	NULL
data	NULL
show	NULL
fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
relative	NULL
to	NULL
the	NULL
control	NULL
response	NULL
calculated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Results	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
are	NULL
presented	NULL
.	NULL

B	NULL
,	NULL
the	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
A	NULL
except	NULL
that	NULL
PKC	NULL
mutant	NULL
or	NULL
wild	NULL
type	NULL
expression	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
with	NULL
NF-KB	NULL
CAT	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
one	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
five	NULL
.	NULL

For	NULL
these	NULL
five	NULL
experiments	NULL
the	NULL
mean	NULL
fold	NULL
increase	NULL
of	NULL
the	NULL
control	NULL
response	NULL
for	NULL
PDBu	NULL
or	NULL
PKC-eE159	NULL
was	NULL
3-	NULL
and	NULL
4-fold	NULL
,	NULL
respectively	NULL
.	NULL

C	NULL
,	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NF-KB-CAT	NULL
reporter	NULL
construct	NULL
and	NULL
empty	NULL
vector	NULL
or	NULL
PKC-a	NULL
«	NULL
E25	NULL
or	NULL
PKC-eE159	NULL
plasmids	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
immediately	NULL
after	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
transfection	NULL
and	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

9837	NULL
{	NULL
E119	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
or	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
PKC	NULL
mutants	NULL
in	NULL
combination	NULL
with	NULL
v-Ha-ras	NULL
.	NULL

However	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
any	NULL
PKC	NULL
construct	NULL
,	NULL
either	NULL
active	NULL
PKC	NULL
or	NULL
wt	NULL
PKC	NULL
,	NULL
were	NULL
still	NULL
able	NULL
to	NULL
induce	NULL
CD69	NULL
upon	NULL
PDBu	NULL
treatment	NULL
or	NULL
T	NULL
cell	NULL
receptor-CD3	NULL
complex	NULL
ligation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
all	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
functional	NULL
constitutively	NULL
active	NULL
PKC-aB25	NULL
or	NULL
PKC-eE159	NULL
was	NULL
monitored	NULL
by	NULL
transactivation	NULL
of	NULL
an	NULL
AP-1-CAT	NULL
reporter	NULL
gene	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
signals	NULL
from	NULL
PKC	NULL
and	NULL
p21	NULL
``	NULL
converge	NULL
to	NULL
control	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
protein	NULL
serine/threonine	NULL
kinase	NULL
Raf-1	NULL
(	NULL
29	NULL
)	NULL
;	NULL
we	NULL
therefore	NULL
examined	NULL
the	NULL
functional	NULL
effect	NULL
of	NULL
expressing	NULL
a	NULL
constitutively	NULL
active	NULL
Raf	NULL
kinase	NULL
,	NULL
partly	NULL
to	NULL
determine	NULL
whether	NULL
there	NULL
were	NULL
any	NULL
intrinsic	NULL
difficulties	NULL
in	NULL
using	NULL
activated	NULL
protein	NULL
serine/threonine	NULL
kinases	NULL
for	NULL
the	NULL
CD69	NULL
induction	NULL
assay	NULL
.	NULL

Preliminary	NULL
experiments	NULL
confirmed	NULL
that	NULL
a	NULL
truncated	NULL
Raf	NULL
protein	NULL
,	NULL
v-raf	NULL
,	NULL
could	NULL
replace	NULL
activated	NULL
p21	NULL
``	NULL
**	NULL
or	NULL
phorbol	NULL
esters	NULL
for	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
in	NULL
CAT	NULL
assays	NULL
.	NULL

Expression	NULL
of	NULL
v-raf	NULL
could	NULL
also	NULL
mimic	NULL
the	NULL
effect	NULL
of	NULL
v-Ha-ras	NULL
for	NULL
CD69	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

5e	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
series	NULL
of	NULL
experiments	NULL
have	NULL
explored	NULL
the	NULL
ability	NULL
of	NULL
constitutively	NULL
active	NULL
pseudosubstrate	NULL
mutated	NULL
variants	NULL
of	NULL
PKC-	NULL
«	NULL
,	NULL
PKC-e	NULL
,	NULL
or	NULL
PKC-£	NULL
to	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
transcriptional	NULL
factors	NULL
AP-1	NULL
,	NULL
NF-AT-1	NULL
,	NULL
and	NULL
NF-KB	NULL
.	NULL

Phorbol	NULL
esters	NULL
can	NULL
stimulate	NULL
AP-1	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
synergize	NULL
with	NULL
calcium	NULL
signals	NULL
to	NULL
regulate	NULL
NF-AT-1	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
the	NULL
constitutively	NULL
active	NULL
mutants	NULL
of	NULL
PKC-	NULL
«	NULL
and	NULL
-e	NULL
,	NULL
PKC-a625	NULL
,	NULL
PKC-eE159	NULL
,	NULL
can	NULL
mimic	NULL
phorbol	NULL
esters	NULL
for	NULL
both	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
induction	NULL
.	NULL

However	NULL
,	NULL
the	NULL
phorbol	NULL
ester	NULL
effect	NULL
on	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
was	NULL
not	NULL
mimicked	NULL
by	NULL
mutated	NULL
PKC-/	NULL
.	NULL

Moreover	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
constitutively	NULL
active	NULL
PKC-	NULL
{	NULL
E119	NULL
alone	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
any	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
responses	NULL
examined	NULL
and	NULL
this	NULL
enzyme	NULL
must	NULL
therefore	NULL
have	NULL
a	NULL
different	NULL
role	NULL
in	NULL
T	NULL
cells	NULL
than	NULL
the	NULL
phorbol	NULL
ester/DAG	NULL
regulated	NULL
PKC	NULL
isotypes	NULL
such	NULL
as	NULL
PKC-a	NULL
or	NULL
-e.	NULL
The	NULL
failure	NULL
of	NULL
the	NULL
activated	NULL
PKC-£	NULL
mutant	NULL
to	NULL
mimic	NULL
phorbol	NULL
ester	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
is	NULL
not	NULL
unexpected	NULL
since	NULL
this	NULL
enzyme	NULL
is	NULL
not	NULL
regulated	NULL
by	NULL
phorbol	NULL
esters	NULL
,	NULL
either	NULL
in	NULL
vitro	NULL
or	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
response	NULL
of	NULL
PKC-£	NULL
to	NULL
phorbol	NULL
esters	NULL
does	NULL
not	NULL
preclude	NULL
that	NULL
this	NULL
enzyme	NULL
might	NULL
have	NULL
some	NULL
functional	NULL
effects	NULL
on	NULL
T	NULL
cell	NULL
activation	NULL
which	NULL
could	NULL
reflect	NULL
its	NULL
involvement	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
controlled	NULL
by	NULL
other	NULL
lipid	NULL
second	NULL
messengers	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
vitro	NULL
,	NULL
shares	NULL
with	NULL
other	NULL
PKC	NULL
isotypes	NULL
the	NULL
ability	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
D-3	NULL
phosphoinositide	NULL
phos-phatidylinositol	NULL
3,4,5-trisphosphate	NULL
(	NULL
80	NULL
)	NULL
.	NULL

As	NULL
well	NULL
,	NULL
experiments	NULL
in	NULL
fibroblasts	NULL
using	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
PKC-£	NULL
or	NULL
overexpression	NULL
of	NULL
PKC-	NULL
{	NULL
wt	NULL
have	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
this	NULL
PKC	NULL
isotype	NULL
in	NULL
NF-KB	NULL
induction	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
PKC-£	NULL
or	NULL
the	NULL
overexpression	NULL
of	NULL
PKC-/wt	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
NF-KB	NULL
transactivation	NULL
in	NULL
T	NULL
cells	NULL
which	NULL
could	NULL
reflect	NULL
that	NULL
the	NULL
mechanisms	NULL
of	NULL
NF-KB	NULL
regulation	NULL
in	NULL
T	NULL
cell	NULL
and	NULL
fibroblasts	NULL
differ	NULL
.	NULL

One	NULL
aim	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
see	NULL
whether	NULL
PKC-a	NULL
and	NULL
-e	NULL
have	NULL
different	NULL
functional	NULL
effects	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
the	NULL
constitutively	NULL
active	NULL
PKC-	NULL
«	NULL
£25	NULL
and	NULL
PKC-eE159	NULL
have	NULL
similar	NULL
effects	NULL
on	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
induction	NULL
,	NULL
but	NULL
are	NULL
different	NULL
in	NULL
that	NULL
PKC-eE159	NULL
could	NULL
transactivate	NULL
an	NULL
NF-KB	NULL
reporter	NULL
gene	NULL
,	NULL
whereas	NULL
PKC-aR25	NULL
could	NULL
not	NULL
.	NULL

was	NULL
consistently	NULL
less	NULL
efficient	NULL
than	NULL
PKC-eE159	NULL
for	NULL
transactivation	NULL
of	NULL
NF-AT-1	NULL
or	NULL
AP-1	NULL
.	NULL

The	NULL
explanation	NULL
for	NULL
this	NULL
difference	NULL
is	NULL
not	NULL
known	NULL
and	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
it	NULL
reflects	NULL
that	NULL
PKC-oB25	NULL
is	NULL
less	NULL
efficiently	NULL
expressed	NULL
than	NULL
PKC-eE159	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
intrinsic	NULL
differences	NULL
in	NULL
the	NULL
stability	NULL
of	NULL
these	NULL
two	NULL
mutated	NULL
PKC	NULL
isotypes	NULL
.	NULL

This	NULL
point	NULL
was	NULL
difficult	NULL
to	NULL
assess	NULL
since	NULL
transfected	NULL
PKC-a625	NULL
and	NULL
PKC-eE159	NULL
could	NULL
not	NULL
be	NULL
dissociated	NULL
from	NULL
their	NULL
endogenous	NULL
(	NULL
wild	NULL
type	NULL
)	NULL
counterparts	NULL
in	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

However	NULL
,	NULL
the	NULL
9838	NULL
Protein	NULL
Kinase	NULL
C	NULL
in	NULL
T	NULL
Cell	NULL
Activation	NULL
V3	NULL
:	NULL
EG1103C003NFL1NCDEY-FITC	NULL
V3	NULL
:	NULL
EG1103CB19NFL1\OX34G	NULL
rat	NULL
CD2	NULL
U3	NULL
:	NULL
EG1103COGSNFL1\CDES-FITC	NULL
V3	NULL
:	NULL
EG1103COOONFL1NCDEY-F	NULL
ITC	NULL
V-SPC	NULL
w	NULL
o	NULL
v-Ha-ras	NULL
e	NULL
v-raf	NULL
V3	NULL
:	NULL
EG1103CO11NFL1NCDEY-FITC	NULL
V3	NULL
:	NULL
EG1183CO12NFL1NCOEY-FITC	NULL
V3	NULL
:	NULL
EG11G3C	NULL
@	NULL
13SFL1NCDEY-FITC	NULL
f	NULL
,	NULL
pkc-alphaE25	NULL
pkc-epsilonE159	NULL
®	NULL
)	NULL
hn	NULL
pkc-zetaE1i19	NULL
590	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PKC-	NULL
«	NULL
,	NULL
-e	NULL
,	NULL
and	NULL
-	NULL
{	NULL
on	NULL
CD69	NULL
expression	NULL
.	NULL

10	NULL
``	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
one	NULL
of	NULL
the	NULL
expression	NULL
vectors	NULL
containing	NULL
either	NULL
a	NULL
mutant	NULL
or	NULL
a	NULL
wild	NULL
type	NULL
PKC-a	NULL
,	NULL
-e	NULL
,	NULL
-	NULL
{	NULL
,	NULL
v-sre	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
rat	NULL
CD2	NULL
,	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PDBu	NULL
,	NULL
4	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
18	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
CD69	NULL
expression	NULL
and	NULL
histogram	NULL
analysis	NULL
of	NULL
CD69	NULL
induction	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
are	NULL
shown	NULL
.	NULL

Log	NULL
of	NULL
fluorescence	NULL
intensity	NULL
is	NULL
measured	NULL
on	NULL
the	NULL
x	NULL
axis	NULL
and	NULL
cell	NULL
number	NULL
on	NULL
the	NULL
y	NULL
axis	NULL
.	NULL

Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
rat	NULL
CD2	NULL
were	NULL
analyzed	NULL
for	NULL
rat	NULL
CD2	NULL
expression	NULL
in	NULL
b	NULL
,	NULL
while	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
anti-CD69	NULL
antibodies	NULL
in	NULL
panels	NULL
a	NULL
and	NULL
c-A	NULL
.	NULL

Unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
white	NULL
histogram	NULL
while	NULL
cells	NULL
stimulated	NULL
with	NULL
PDBu	NULL
(	NULL
a	NULL
)	NULL
or	NULL
transfected	NULL
with	NULL
an	NULL
active	NULL
plasmid	NULL
(	NULL
c-	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
black	NULL
histogram	NULL
.	NULL

Staining	NULL
is	NULL
shown	NULL
with	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
and	NULL
with	NULL
PDBu	NULL
stimulation	NULL
(	NULL
a	NULL
)	NULL
;	NULL
c	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
v-src	NULL
;	NULL
d	NULL
,	NULL
with	NULL
v-Ha-ras	NULL
;	NULL
e	NULL
,	NULL
with	NULL
PKC-a625	NULL
mutant	NULL
;	NULL
f	NULL
,	NULL
with	NULL
PKC-eE25	NULL
mutant	NULL
;	NULL
g	NULL
,	NULL
with	NULL
PKC-	NULL
{	NULL
E119	NULL
mutant	NULL
.	NULL

The	NULL
data	NULL
from	NULL
one	NULL
experiment	NULL
are	NULL
shown	NULL
but	NULL
seven	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
based	NULL
on	NULL
rat	NULL
CD2	NULL
expression	NULL
ranged	NULL
from	NULL
30	NULL
to	NULL
38	NULL
%	NULL
;	NULL
83.5	NULL
+	NULL
2.2	NULL
%	NULL
CD69	NULL
positive	NULL
cells	NULL
were	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
transfection	NULL
with	NULL
v-sre	NULL
;	NULL
16.3	NULL
+	NULL
6.3	NULL
%	NULL
CD69	NULL
positive	NULL
cells	NULL
were	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
transfection	NULL
with	NULL
v-Ha-ras	NULL
;	NULL
11.9	NULL
+	NULL
1.3	NULL
%	NULL
CD69	NULL
positive	NULL
cells	NULL
were	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
transfection	NULL
with	NULL
v-rof	NULL
;	NULL
1.2	NULL
+	NULL
1.8	NULL
%	NULL
CD69	NULL
positive	NULL
cells	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
transfection	NULL
with	NULL
PKC-aB25	NULL
;	NULL
1.5	NULL
+	NULL
1.9	NULL
%	NULL
CD69	NULL
positive	NULL
cells	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
transfection	NULL
with	NULL
PKC-eE159	NULL
;	NULL
2.2	NULL
+	NULL
2.1	NULL
%	NULL
CD69	NULL
positive	NULL
cells	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
transfection	NULL
with	NULL
PKC-£E119	NULL
.	NULL

differences	NULL
between	NULL
PKC-oE25	NULL
compared	NULL
to	NULL
PKC-eE159	NULL
for	NULL
-	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
family	NULL
of	NULL
transcriptional	NULL
factors	NULL
.	NULL

AP-1	NULL
and	NULL
NF-AT-1	NULL
activation	NULL
were	NULL
at	NULL
most	NULL
2-fold	NULL
.	NULL

The	NULL
sensi-	NULL
In	NULL
T	NULL
cells	NULL
,	NULL
phorbol	NULL
esters	NULL
and	NULL
DAGs	NULL
stimulate	NULL
the	NULL
accumu-tivity	NULL
of	NULL
the	NULL
NF-KB	NULL
assay	NULL
would	NULL
have	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
-	NULL
lation	NULL
of	NULL
``	NULL
active	NULL
``	NULL
p21	NULL
``	NULL
**-GTP	NULL
complexes	NULL
in	NULL
a	NULL
PKC-dependent	NULL
a	NULL
2-fold	NULL
difference	NULL
in	NULL
the	NULL
effect	NULL
of	NULL
PKC-a625	NULL
and	NULL
PKC-eE159	NULL
.	NULL

-	NULL
response	NULL
(	NULL
32	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
,	NULL
combined	NULL
with	NULL
a	NULL
requirement	NULL
Accordingly	NULL
,	NULL
it	NULL
would	NULL
seem	NULL
that	NULL
there	NULL
is	NULL
a	NULL
real	NULL
difference	NULL
in	NULL
the	NULL
-	NULL
for	NULL
Ras	NULL
function	NULL
for	NULL
phorbol	NULL
ester	NULL
regulation	NULL
of	NULL
interleukin	NULL
2	NULL
relative	NULL
ability	NULL
of	NULL
PKC-	NULL
«	NULL
E25	NULL
and	NULL
PKC-eE159	NULL
to	NULL
regulate	NULL
the	NULL
-	NULL
gene	NULL
expression	NULL
(	NULL
8	NULL
)	NULL
led	NULL
to	NULL
the	NULL
idea	NULL
that	NULL
PKC	NULL
functioned	NULL
up	NULL
Protein	NULL
Kinase	NULL
C	NULL
in	NULL
T	NULL
Cell	NULL
Activation	NULL
stream	NULL
of	NULL
p21	NULL
``	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
PKC	NULL
and	NULL
Ras	NULL
in	NULL
other	NULL
cell	NULL
lineages	NULL
is	NULL
more	NULL
complicated	NULL
,	NULL
par-ticularily	NULL
in	NULL
fibroblasts	NULL
,	NULL
where	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
PKC	NULL
may	NULL
function	NULL
both	NULL
upstream	NULL
and	NULL
downstream	NULL
of	NULL
Ras	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
compared	NULL
the	NULL
effect	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
Ras	NULL
protein	NULL
and	NULL
constitutively	NULL
active	NULL
PKC-a	NULL
and	NULL
-e	NULL
mutants	NULL
on	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

If	NULL
either	NULL
of	NULL
these	NULL
isotypes	NULL
functioned	NULL
directly	NULL
upstream	NULL
or	NULL
downstream	NULL
of	NULL
p21	NULL
``	NULL
,	NULL
then	NULL
it	NULL
would	NULL
be	NULL
expected	NULL
that	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
the	NULL
active	NULL
PKC	NULL
mutants	NULL
,	NULL
PKC-aBE25	NULL
and	NULL
PKC-eE159	NULL
,	NULL
would	NULL
be	NULL
the	NULL
same	NULL
as	NULL
the	NULL
effects	NULL
of	NULL
an	NULL
``	NULL
activated	NULL
``	NULL
Ras	NULL
protein	NULL
,	NULL
p21	NULL
``	NULL
~	NULL
``	NULL
*	NULL
``	NULL
*	NULL
,	NULL
For	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
induction	NULL
,	NULL
p21Y	NULL
``	NULL
*	NULL
``	NULL
*	NULL
``	NULL
,	NULL
PKC-	NULL
«	NULL
E25	NULL
,	NULL
or	NULL
PKC-eE159	NULL
have	NULL
comparable	NULL
effects	NULL
and	NULL
can	NULL
mimic	NULL
the	NULL
effect	NULL
of	NULL
phorbol	NULL
esters	NULL
.	NULL

However	NULL
,	NULL
PKC-eE159	NULL
could	NULL
stimulate	NULL
NF-KB	NULL
,	NULL
whereas	NULL
the	NULL
activated	NULL
Ras	NULL
mutant	NULL
could	NULL
not	NULL
,	NULL
which	NULL
indicates	NULL
clearly	NULL
that	NULL
not	NULL
all	NULL
PKC	NULL
functions	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
mediated	NULL
by	NULL
p21	NULL
``	NULL
.	NULL

p21	NULL
``	NULL
**	NULL
controlled	NULL
signaling	NULL
pathways	NULL
are	NULL
necessary	NULL
for	NULL
regulating	NULL
surface	NULL
levels	NULL
of	NULL
the	NULL
CD69	NULL
antigen	NULL
and	NULL
thus	NULL
transfection	NULL
of	NULL
p21	NULL
``	NULL
alone	NULL
into	NULL
Jurkat	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
(	NULL
25	NULL
)	NULL
.	NULL

If	NULL
PKC-a	NULL
or	NULL
-e	NULL
function	NULL
upstream	NULL
of	NULL
p21	NULL
``	NULL
then	NULL
it	NULL
would	NULL
be	NULL
predicted	NULL
that	NULL
cells	NULL
transfected	NULL
with	NULL
activated	NULL
mutants	NULL
of	NULL
PKC	NULL
would	NULL
also	NULL
express	NULL
CD69	NULL
.	NULL

The	NULL
data	NULL
in	NULL
the	NULL
present	NULL
report	NULL
show	NULL
that	NULL
phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
induces	NULL
CD69	NULL
as	NULL
does	NULL
transfection	NULL
of	NULL
v-sre	NULL
.	NULL

Transfection	NULL
of	NULL
v-Ha-ras	NULL
is	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
CD69	NULL
in	NULL
JH6.2	NULL
cells	NULL
,	NULL
although	NULL
consistently	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
than	NULL
v-src	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
PKC-aE25	NULL
and	NULL
PKC-eE159	NULL
failed	NULL
to	NULL
induce	NULL
CD69	NULL
expression	NULL
.	NULL

The	NULL
implication	NULL
from	NULL
these	NULL
data	NULL
are	NULL
that	NULL
phorbol	NULL
ester	NULL
induction	NULL
of	NULL
CD69	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
PKC-a	NULL
«	NULL
or	NULL
PKC-e	NULL
,	NULL
and	NULL
therefore	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
another	NULL
PKC	NULL
isotype	NULL
or	NULL
,	NULL
alternatively	NULL
by	NULL
another	NULL
phorbol	NULL
ester-dependent	NULL
effector	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
neither	NULL
PKC-a	NULL
nor	NULL
PKC-e	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
p21	NULL
``	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
p21	NULL
``	NULL
functions	NULL
upstream	NULL
of	NULL
the	NULL
protein	NULL
serine/threonine	NULL
kinase	NULL
Raf-1	NULL
in	NULL
many	NULL
cells	NULL
,	NULL
and	NULL
thus	NULL
cells	NULL
expressing	NULL
constitutively	NULL
activated	NULL
Ras	NULL
and	NULL
Raf	NULL
proteins	NULL
have	NULL
a	NULL
similar	NULL
phenotype	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
v-Ha-ras	NULL
and	NULL
v-raf	NULL
have	NULL
a	NULL
comparable	NULL
effect	NULL
on	NULL
CD69	NULL
expression	NULL
which	NULL
illustrates	NULL
that	NULL
there	NULL
is	NULL
no	NULL
intrinsic	NULL
problem	NULL
associated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
CD69	NULL
by	NULL
a	NULL
constitutively	NULL
active	NULL
protein	NULL
serine/	NULL
threonine	NULL
kinase	NULL
.	NULL

Thus	NULL
the	NULL
simplest	NULL
interpretation	NULL
of	NULL
differences	NULL
between	NULL
the	NULL
functional	NULL
effects	NULL
of	NULL
v-Ha-ras	NULL
and	NULL
PKC-a625	NULL
or	NULL
PKC-eE159	NULL
with	NULL
regard	NULL
to	NULL
CD69	NULL
induction	NULL
is	NULL
that	NULL
these	NULL
molecules	NULL
are	NULL
not	NULL
positioned	NULL
linearily	NULL
in	NULL
the	NULL
same	NULL
signaling	NULL
pathway	NULL
.	NULL

Nevertheless	NULL
,	NULL
their	NULL
similar	NULL
effects	NULL
on	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
induction	NULL
indicated	NULL
that	NULL
there	NULL
must	NULL
be	NULL
some	NULL
point	NULL
of	NULL
convergence	NULL
of	NULL
Ras	NULL
and	NULL
PKC-	NULL
@	NULL
w/e	NULL
signals	NULL
.	NULL

One	NULL
such	NULL
convergence	NULL
point	NULL
for	NULL
Ras	NULL
and	NULL
PKC	NULL
could	NULL
be	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
extracellular	NULL
signal-regulated	NULL
or	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
ERKs/	NULL
MAPKs	NULL
)	NULL
cascade	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
express	NULL
more	NULL
than	NULL
one	NULL
member	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
family	NULL
including	NULL
ERK-2	NULL
and	NULL
JNK-1	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
possible	NULL
that	NULL
p21	NULL
**	NULL
and	NULL
PKC-a	NULL
and	NULL
-e	NULL
activate	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
via	NULL
parallel	NULL
pathways	NULL
that	NULL
use	NULL
different	NULL
members	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
family	NULL
.	NULL

The	NULL
point	NULL
of	NULL
convergence	NULL
of	NULL
the	NULL
signaling	NULL
pathways	NULL
would	NULL
thus	NULL
be	NULL
in	NULL
the	NULL
nucleus	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcrip-	NULL
9839	NULL
tional	NULL
factor	NULL
phosphorylation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
it	NULL
has	NULL
been	NULL
known	NULL
for	NULL
several	NULL
years	NULL
that	NULL
T	NULL
cells	NULL
express	NULL
multiple	NULL
isoforms	NULL
of	NULL
PKC	NULL
.	NULL

The	NULL
present	NULL
study	NULL
has	NULL
shown	NULL
that	NULL
phorbol	NULL
ester	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
factors	NULL
AP-1	NULL
and	NULL
NF-AT-1	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
constitutively	NULL
active	NULL
PKC-a	NULL
and	NULL
-e.	NULL
PKC-e	NULL
can	NULL
transactivate	NULL
NF-KB	NULL
whereas	NULL
PKC-a	NULL
«	NULL
could	NULL
not	NULL
.	NULL

PKC-£¢	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
AP-1	NULL
,	NULL
NF-AT-1	NULL
,	NULL
or	NULL
NF-KB	NULL
transactivation	NULL
and	NULL
its	NULL
role	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
yet	NULL
discov-ered	NULL
.	NULL

These	NULL
experiments	NULL
indicate	NULL
that	NULL
different	NULL
PKC	NULL
isotypes	NULL
may	NULL
have	NULL
selective	NULL
physiological	NULL
functions	NULL
in	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Littman	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
263-274	NULL
2	NULL
.	NULL

Berry	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

189	NULL
,	NULL
205-214	NULL
3	NULL
.	NULL

Hug	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Sarre	NULL
,	NULL
T.	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

291	NULL
,	NULL
329-343	NULL
4	NULL
.	NULL

Dekker	NULL
,	NULL
L.	NULL
V.	NULL
,	NULL
and	NULL
Parker	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
73-77	NULL
5	NULL
.	NULL

Johannes	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Pretle	NULL
,	NULL
J.	NULL
,	NULL
Eis	NULL
,	NULL
S.	NULL
,	NULL
Oberhagemann	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Pfizenmaier	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
6140-6148	NULL
6	NULL
.	NULL

Valverde	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Sinnett-Smith	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
Lint	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Rozengurt	NULL
,	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
8572-8576	NULL
7	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
8	NULL
.	NULL

Rayter	NULL
,	NULL
S.	NULL
,	NULL
Woodrow	NULL
,	NULL
M.	NULL
,	NULL
Lucas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Cantrell	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Downward	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
4549-4556	NULL
9	NULL
.	NULL

Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

227	NULL
,	NULL
470-473	NULL
10	NULL
.	NULL

Baier	NULL
,	NULL
G.	NULL
,	NULL
Telford	NULL
,	NULL
D.	NULL
,	NULL
Giampa	NULL
,	NULL
L.	NULL
,	NULL
Coggeshall	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Baier-	NULL
Bitterlich	NULL
,	NULL
G.	NULL
,	NULL
Isakov	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Altman	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
4997-5004	NULL
11	NULL
.	NULL

Ahmed	NULL
,	NULL
S.	NULL
,	NULL
Kozma	NULL
,	NULL
R.	NULL
,	NULL
Lee	NULL
,	NULL
J.	NULL
,	NULL
Monfries	NULL
,	NULL
C.	NULL
,	NULL
Harden	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Lim	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

280	NULL
,	NULL
233-241	NULL
12	NULL
.	NULL

Woodrow	NULL
,	NULL
M.	NULL
,	NULL
Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1517-1522	NULL
13	NULL
.	NULL

Wotton	NULL
,	NULL
D.	NULL
,	NULL
Ways	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Parker	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
17975-17982	NULL
14	NULL
.	NULL

Muramatsu	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Kaibuchi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.	NULL
I	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
831-836	NULL
15	NULL
.	NULL

Orr	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Keranen	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Newton	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
15263-15266	NULL
16	NULL
.	NULL

Pears	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Kour	NULL
,	NULL
G.	NULL
,	NULL
House	NULL
,	NULL
C.	NULL
,	NULL
Kemp	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
Parker	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

194	NULL
,	NULL
89-94	NULL
17	NULL
.	NULL

Tsutsumi	NULL
,	NULL
A.	NULL
,	NULL
Kubo	NULL
,	NULL
M.	NULL
,	NULL
Fujii	NULL
,	NULL
H.	NULL
,	NULL
Freire-Moar	NULL
,	NULL
J.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Ransom	NULL
,	NULL
J.	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
1754-1756	NULL
18	NULL
.	NULL

Williams	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Teffery	NULL
,	NULL
L.	NULL
T.	NULL
,	NULL
and	NULL
Murray	NULL
,	NULL
E.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1180	NULL
,	NULL
9-14	NULL
19	NULL
.	NULL

Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
18	NULL
,	NULL
136-142	NULL
20	NULL
.	NULL

Parker	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Coussens	NULL
,	NULL
L.	NULL
,	NULL
Totty	NULL
,	NULL
N.	NULL
,	NULL
Rhee	NULL
,	NULL
L.	NULL
,	NULL
Young	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
E.	NULL
,	NULL
Stabel	NULL
,	NULL
S.	NULL
,	NULL
Waterfield	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
Ullrich	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
853-859	NULL
21	NULL
.	NULL

Schaap	NULL
,	NULL
D.	NULL
,	NULL
Parker	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Bristol	NULL
,	NULL
A.	NULL
,	NULL
Kriz	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Knopf	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

243	NULL
,	NULL
352-357	NULL
22	NULL
.	NULL

Ono	NULL
,	NULL
Y.	NULL
,	NULL
Fuiji	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ogika	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
3099-3103	NULL
23	NULL
.	NULL

Goode	NULL
,	NULL
N.	NULL
T.	NULL
,	NULL
and	NULL
Parker	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

840	NULL
,	NULL
145-150	NULL
24	NULL
.	NULL

Decock	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
J.	NULL
,	NULL
Parker	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Sugden	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Fuller	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

356	NULL
,	NULL
275-278	NULL
25	NULL
.	NULL

D'Ambrosio	NULL
,	NULL
D.	NULL
,	NULL
Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Frati	NULL
,	NULL
L.	NULL
,	NULL
Santoni	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Testi	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24	NULL
,	NULL
616-620	NULL
26	NULL
.	NULL

Nunés	NULL
,	NULL
J.	NULL
,	NULL
Klasen	NULL
,	NULL
S.	NULL
,	NULL
Ragueneau	NULL
,	NULL
M.	NULL
,	NULL
Pavon	NULL
,	NULL
C.	NULL
,	NULL
Couez	NULL
,	NULL
D.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

5	NULL
,	NULL
811-315	NULL
27	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Bauerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

290	NULL
,	NULL
297-308	NULL
28	NULL
.	NULL

Hara	NULL
,	NULL
T.	NULL
,	NULL
Jung	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Bjorndahl	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164	NULL
,	NULL
1988-1999	NULL
29	NULL
.	NULL

Daum	NULL
,	NULL
G.	NULL
,	NULL
Eisenmann-Tappe	NULL
,	NULL
L.	NULL
,	NULL
Fries	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Troppmair	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

227	NULL
,	NULL
474-480	NULL
30	NULL
.	NULL

Liscovitch	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
329-334	NULL
31	NULL
.	NULL

Berra	NULL
,	NULL
E.	NULL
,	NULL
Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Dominguez	NULL
,	NULL
I.	NULL
,	NULL
Municio	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Sanz	NULL
,	NULL
L.	NULL
,	NULL
Lozano	NULL
,	NULL
J.	NULL
,	NULL
Chapkin	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Moscat	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
555-563	NULL
32	NULL
.	NULL

Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
Downward	NULL
,	NULL
J.	NULL
,	NULL
Graves	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3305-3312	NULL
38	NULL
.	NULL

Pulverer	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Hughes	NULL
,	NULL
K.	NULL
,	NULL
Franklin	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Leevers	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
407-415	NULL
34	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
L-H.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
B.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
1025-1037	NULL
35	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
Jacinto	NULL
,	NULL
E.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
727-736	NULL

